Jefferson Institute for Bioprocessing: Site plan and launch update
Philadelphia’s Jefferson University – the result of a merger between Philadelphia University and Thomas Jefferson University – has announced its bioprocessing institute will open in the first half of 2019.
The 133-acre Spring House Innovation Park campus, located in Lower Gwynedd, Pennsylvania, will house the 25,000 sq. ft. Institute, designed to educate 2,500 people per year, including industry professionals and Jefferson University students.
“Our facility at Spring House Innovation Park will utilise leading-edge biopharmaceutical manufacturing technology and support current and future workforce demands in this critically important field,” said associate provost for applied research at Jefferson (Philadelphia University + Thomas Jefferson University) Ron Kander in a statement.
The Jefferson Institute for Bioprocessing was first announced in partnership with Ireland’s National Institute for Bioprocessing Research and Training (NIBRT) in February this year.
At the time, NIBRT CEO Dominic Carolan said the new Institute responds to an increased demand for biologic drugs: “There is a significant demand for global talent to support the growth of the biopharmaceutical manufacturing industry and our relationship with Jefferson will help address this demand throughout the United States.”
